[CAPR] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CAPR] Capricor Therapeutics, Inc.
Announcement Date
13-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 21.23%
YoY- 48.72%
Quarter Report
CAPR's Result
CAPR's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 17 142 219 313 684 911 1,301 -51.43%
PBT -3,910 -1,607 -4,136 -2,735 -5,333 -2,912 -1,544 16.73%
Tax -40 -64 0 74 72 33 60 -
NP -3,910 -1,607 -4,136 -2,735 -5,333 -2,912 -1,544 16.73%
Tax Rate - - - - - - - -
Total Cost 3,927 1,749 4,355 3,048 6,017 3,823 2,845 5.51%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -23,187.59 -1,130.84 -1,886.52 -873.04 -780.20 -319.48 -118.63 140.71%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.20 -0.43 -1.35 -1.17 -2.92 -1.79 -1.32 -26.96%
EPS Diluted -0.20 -0.43 -1.35 -1.17 -2.92 -1.79 -1.32 -26.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.